Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Chang Seok Song"

Keywords

Publication year

"Chang Seok Song"

Original Article

Steatotic liver disease

Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH
Min Yong Yoon, Jun Mo Sung, Chang Seok Song, Won Young Lee, Eun Jung Rhee, Jun Ho Shin, Chang Hak Yoo, Seoung Wan Chae, Ja Yeon Kim, Wook Jin, Yong Kyun Cho
Korean J Hepatol 2012;18(3):279-286.
Published online September 25, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.3.279
Background/Aims

Adipose tissue is an active endocrine organ that secretes various metabolically important substances including adipokines, which represent a link between insulin resistance and nonalcoholic steatohepatitis (NASH). The factors responsible for the progression from simple steatosis to steatohepatitis remain elusive, but adipokine imbalance may play a pivotal role. We evaluated the expressions of adipokines such as visfatin, adipocyte-fatty-acid-binding protein (A-FABP), and retinol-binding protein-4 (RBP-4) in serum and tissue. The aim was to discover whether these adipokines are potential predictors of NASH.

Methods

Polymerase chain reaction, quantification of mRNA, and Western blots encoding A-FABP, RBP-4, and visfatin were used to study tissue samples from the liver, and visceral and subcutaneous adipose tissue. The tissue samples were from biopsy specimens obtained from patients with proven NASH who were undergoing laparoscopic cholecystectomy due to gallbladder polyps.

Results

Patients were classified into two groups: NASH, n=10 and non-NASH, n=20 according to their nonalcoholic fatty liver disease Activity Score. Although serum A-FABP levels did not differ between the two groups, the expressions of A-FABP mRNA and protein in the visceral adipose tissue were significantly higher in NASH group than in non-NASH group (104.34 vs. 97.05, P<0.05, and 190.01 vs. 95.15, P<0.01, respectively). Furthermore, the A-FABP protein expression ratio between visceral adipose tissue and liver was higher in NASH group than in non-NASH group (4.38 vs. 1.64, P<0.05).

Conclusions

NASH patients had higher levels of A-FABP expression in their visceral fat compared to non-NASH patients. This differential A-FABP expression may predispose patients to the progressive form of NASH.

Citations

Citations to this article as recorded by  Crossref logo
  • The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
    Milton Packer
    JACC.2025; 86(16): 1269.     CrossRef
  • FABP4 Expression in Subcutaneous Adipose Tissue Is Independently Associated with Circulating Triglycerides in Obesity
    Óscar Osorio-Conles, Ainitze Ibarzabal, José María Balibrea, Josep Vidal, Emilio Ortega, Ana de Hollanda
    Journal of Clinical Medicine.2023; 12(3): 1013.     CrossRef
  • Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
    Juan Moreno-Vedia, Josefa Girona, Daiana Ibarretxe, Lluís Masana, Ricardo Rodríguez-Calvo
    Biomedicines.2022; 10(1): 197.     CrossRef
  • Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
    Vera Francisco, Maria Jesus Sanz, José T. Real, Patrice Marques, Maurizio Capuozzo, Djedjiga Ait Eldjoudi, Oreste Gualillo
    Biology.2022; 11(8): 1237.     CrossRef
  • Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
    Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu
    Journal of Clinical Medicine.2021; 10(14): 3029.     CrossRef
  • Serum adipocyte fatty acid‐binding protein levels are associated with peripheral arterial disease in women, but not men, with type 2 diabetes mellitus
    Min Ding, Jian‐Ying Shi, Yun‐Zhi XING, Bei Sun, Qian‐Hua Fang, Jing‐Yun Zhang, Qiu‐Mei Zhang, Li‐Ming Chen, De‐min Yu, Chun‐Jun Li
    Journal of Diabetes.2018; 10(6): 478.     CrossRef
  • Adipokines in nonalcoholic fatty liver disease
    Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros
    Metabolism.2016; 65(8): 1062.     CrossRef
  • Association of recently described adipokines with liver histology in biopsy‐proven non‐alcoholic fatty liver disease: a systematic review
    M. Bekaert, X. Verhelst, A. Geerts, B. Lapauw, P. Calders
    Obesity Reviews.2016; 17(1): 68.     CrossRef
  • Evaluation of Circulating Adipokines and Abdominal Obesity as Predictors of Significant Myocardial Ischemia Using Gated Single-Photon Emission Computed Tomography
    Chi-Sheng Hung, Yen-Wen Wu, Jei-Yie Huang, Pei-Ying Hsu, Ming-Fong Chen, Xin-Liang Ma
    PLoS ONE.2014; 9(5): e97710.     CrossRef
  • Serum visfatin in nonalcoholic fatty liver disease
    Stergios A. Polyzos, Jannis Kountouras, lordanis Romiopoulos, Vaia Polymerou
    Annals of Hepatology.2014; 13(1): 150.     CrossRef
  • Systems biology of adipose tissue metabolism: regulation of growth, signaling and inflammation
    Sara Manteiga, Kyungoh Choi, Arul Jayaraman, Kyongbum Lee
    WIREs Systems Biology and Medicine.2013; 5(4): 425.     CrossRef
  • Metabolically Protective Cytokines Adiponectin and Fibroblast Growth Factor-21 Are Increased by Acute Overfeeding in Healthy Humans
    Leonie K. Heilbronn, Lesley V. Campbell, Aimin Xu, Dorit Samocha-Bonet, Jose Galgani
    PLoS ONE.2013; 8(10): e78864.     CrossRef
  • 9,671 View
  • 78 Download
  • Crossref